Related references
Note: Only part of the references are listed.Recent Developments in SPECT/CT
Philipp Ritt
SEMINARS IN NUCLEAR MEDICINE (2022)
Advantages and Applications of Total-Body PET Scanning
Sanaz Katal et al.
DIAGNOSTICS (2022)
Total-body [18F]FDG PET/CT scan has stepped into the arena: the faster, the better. Is it always true?
Luca Filippi et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2022)
Robot-assisted Prostate-specific Membrane Antigen-radioguided Salvage Surgery in Recurrent Prostate Cancer Using a DROP-IN Gamma Probe: The First Prospective Feasibility Study
Hilda A. de Barros et al.
EUROPEAN UROLOGY (2022)
Nuclear-medicine probes: Where we are and where we are going
Andrea Gonzalez-Montoro et al.
MEDICAL PHYSICS (2022)
A Review on the Current State and Future Perspectives of [99mTc]Tc-Housed PSMA-i in Prostate Cancer
Sara Brunello et al.
MOLECULES (2022)
Baseline Imaging Derived Predictive Factors of Response Following [Lu-177]Lu-PSMA-617 Therapy in Salvage Metastatic Castration-Resistant Prostate Cancer: A Lesion- and Patient-Based Analysis
Esmee C. A. van der Sar et al.
BIOMEDICINES (2022)
Progress in large field-of-view interventional planar scintigraphy and SPECT imaging
Martijn M. A. Dietze et al.
EXPERT REVIEW OF MEDICAL DEVICES (2022)
Biomarkers to personalize treatment with 177Lu-PSMA-617 in men with metastatic castration-resistant prostate cancer-a state of the art review
Isabel Heidegger et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2022)
An Impressive Approach in Nuclear Medicine Theranostics
Nasim Vahidfar et al.
PET CLINICS (2021)
SPECT-CT imaging with [99mTc]PSMA-T4 in patients with recurrent prostate cancer
Sonya Sergieva et al.
NUCLEAR MEDICINE REVIEW (2021)
99mTc-PSMA SPECT/CT Versus 68Ga-PSMA PET/CT in the Evaluation of Metastatic Prostate Cancer
Babak Fallahi et al.
CLINICAL NUCLEAR MEDICINE (2021)
Comparison of the diagnostic utility of 99mTc-PSMA scintigraphy versus 68Ga-PSMA-11 PET/CT in the detection of metastatic prostate cancer and dosimetry analysis: a gamma-camera-based alternate prostate-specific membrane antigen imaging modality
Baljinder Singh et al.
NUCLEAR MEDICINE COMMUNICATIONS (2021)
Diagnostic performance of 68Ga-PSMA-11 PET/MRI-guided biopsy in patients with suspected prostate cancer: a prospective single-center study
Daniela A. Ferraro et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
99mTc-labelled PSMA ligand for radio-guided surgery in nodal metastatic prostate cancer: proof of principle
Michael Mix et al.
EJNMMI RESEARCH (2021)
Combination of 99mTc-Labeled PSMA-SPECT/CT and Diffusion-Weighted MRI in the Prediction of Early Response After Carbon Ion Therapy in Prostate Cancer: A Non-Randomized Prospective Pilot Study
Ping Li et al.
CANCER MANAGEMENT AND RESEARCH (2021)
Pharmacokinetic studies of [68 Ga]Ga-PSMA-11 in patients with biochemical recurrence of prostate cancer: detection, differences in temporal distribution and kinetic modelling by tissue type
Dimitrios S. Strauss et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
Radioguided surgery: physical principles and an update on technological developments
Ali Pashazadeh et al.
BIOMEDICAL ENGINEERING-BIOMEDIZINISCHE TECHNIK (2020)
Targeted Alpha Therapy with Thorium-227
Viviana Frantellizzi et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2020)
Prognostic value of neutrophil-to-lymphocyte ratio and its correlation with fluorine-18-fluorodeoxyglucose metabolic parameters in intrahepatic cholangiocarcinoma submitted to 90Y-radioembolization
Luca Filippi et al.
NUCLEAR MEDICINE COMMUNICATIONS (2020)
Exploratory cost-effectiveness analysis of 68Gallium-PSMA PET/MRI-based imaging in patients with biochemical recurrence of prostate cancer
Louisa G. Gordon et al.
CLINICAL & EXPERIMENTAL METASTASIS (2020)
Results from extended lymphadenectomies with [111In]PSMA-617 for intraoperative detection of PSMA-PET/CT-positive nodal metastatic prostate cancer
Cordula A. Jilg et al.
EJNMMI RESEARCH (2020)
Theragnostic Aspects and Radioimmunotherapy in Pediatric Tumors
Andrea Cimini et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study
Michael S. Hofman et al.
LANCET (2020)
[99cmTc]Tc-PSMA-I&S-SPECT/CT: experience in prostate cancer imaging in an outpatient center
P. Werner et al.
EJNMMI RESEARCH (2020)
The potential of PSMA-targeted alpha therapy in the management of prostate cancer
Luca Filippi et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2020)
Prostate-specific membrane antigen (PSMA)-ligand positron emission tomography and radioligand therapy (RLT) of prostate cancer
Ukihide Tateishi
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2020)
A Clinician's Guide to Next Generation Imaging in Patients With Advanced Prostate Cancer (RADAR III)
E. David Crawford et al.
JOURNAL OF UROLOGY (2019)
PSMA-Targeted Radiopharmaceuticals for Imaging and Therapy
Hans-Juergen Wester et al.
SEMINARS IN NUCLEAR MEDICINE (2019)
Two decades of SPECT/CT - the coming of age of a technology: An updated review of literature evidence
Ora Israel et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
A Picture of Modern Tc-99m Radiopharmaceuticals: Production, Chemistry, and Applications in Molecular Imaging
Alessandra Boschi et al.
APPLIED SCIENCES-BASEL (2019)
High resolution and sensitivity gamma camera with active septa. A first Monte Carlo study
Victor Ilisie et al.
SCIENTIFIC REPORTS (2019)
Impact of Resolution Recovery in Quantitative 99mTc SPECT/CT Cardiac Phantom Studies
Faizatul Shahira Ismail et al.
JOURNAL OF MEDICAL IMAGING AND RADIATION SCIENCES (2019)
Preparation and clinical translation of 99mTc-PSMA-11 for SPECT imaging of prostate cancer
Kusum Vats et al.
MEDCHEMCOMM (2019)
Quantitative SPECT: the time is now
John Dickson et al.
EJNMMI PHYSICS (2019)
99mTc-MIP-1404-SPECT/CT for the detection of PSMA-positive lesions in 225 patients with biochemical recurrence of prostate cancer
Christian Schmidkonz et al.
PROSTATE (2018)
A Perspective on the Evolving Story of PSMA Biology, PSMA-Based Imaging, and Endoradiotherapeutic Strategies
Denise S. O'Keefe et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Performance of 111In-labelled PSMA ligand in patients with nodal metastatic prostate cancer: correlation between tracer uptake and histopathology from lymphadenectomy
Michael Mix et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Lu-177-PSMA treatment for metastatic prostate cancer: case examples of major responses
Kalevi Kairemo et al.
CLINICAL AND TRANSLATIONAL IMAGING (2018)
PERCIST in Perspective
Joo Hyun O et al.
NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Value of 111In-prostate-specific membrane antigen (PSMA)-radioguided surgery for salvage lymphadenectomy in recurrent prostate cancer: correlation with histopathology and clinical follow-up
Isabel Rauscher et al.
BJU INTERNATIONAL (2017)
Preclinical Evaluation and First Patient Application of 99mTc-PSMA-I&S for SPECT Imaging and Radioguided Surgery in Prostate Cancer
Stephanie Robu et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Phantom validation of quantitative Y-90 PET/CT-based dosimetry in liver radioembolization
Marco D'Arienzo et al.
EJNMMI RESEARCH (2017)
Whole-body bone SPECT in breast cancer patients: the future bone scan protocol?
Gad Abikhzer et al.
NUCLEAR MEDICINE COMMUNICATIONS (2016)
Intrapatient Comparison of 111In-PSMA I&T SPECT/CT and Hybrid 68Ga-HBED-CC PSMA PET in Patients With Early Recurrent Prostate Cancer
Isabel Rauscher et al.
CLINICAL NUCLEAR MEDICINE (2016)
Towards Personalized Treatment of Prostate Cancer: PSMA I&T, a Promising Prostate-Specific Membrane Antigen-Targeted Theranostic Agent
Kristell L. S. Chatalic et al.
THERANOSTICS (2016)
A modified sentinel node and occult lesion localization (SNOLL) technique in non-palpable breast cancer: a pilot study
Giulia Anna Follacchio et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2015)
Preclinical Evaluation of a Tailor-Made DOTA-Conjugated PSMA Inhibitor with Optimized Linker Moiety for Imaging and Endoradiotherapy of Prostate Cancer
Martina Benesova et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
[111In]PSMA-I&T: expanding the spectrum of PSMA-I&T applications towards SPECT and radioguided surgery
Margret Schottelius et al.
EJNMMI RESEARCH (2015)
The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer
Ali Afshar-Oromieh et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
Whole-body SPECT/CT for bone scintigraphy: diagnostic value and effect on patient management in oncological patients
H. Palmedo et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
Nuclear Probes and Intraoperative Gamma Cameras
Sherman Heller et al.
SEMINARS IN NUCLEAR MEDICINE (2011)
A comprehensive overview of radioguided surgery using gamma detection probe technology
Stephen P. Povoski et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2009)
SPECT/CT with a hybrid camera: a new imaging modality for the functional anatomical mapping of infections
Luca Filippi et al.
EXPERT REVIEW OF MEDICAL DEVICES (2006)
Intraoperative gamma probe detection of head and neck paragangliomas with 111In-pentetreotide:: A pilot study
L Filippi et al.
TUMORI JOURNAL (2005)
New devices for imaging in nuclear medicine
R Pani et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2004)
Share Paper
